Peptidically buffered formulations for electrotransport applications and methods of making
    1.
    发明申请
    Peptidically buffered formulations for electrotransport applications and methods of making 审中-公开
    用于电转运应用的肽缓冲制剂和制备方法

    公开(公告)号:US20050142531A1

    公开(公告)日:2005-06-30

    申请号:US10993649

    申请日:2004-11-19

    摘要: Methods for preparing compositions for use in electrotransport delivery systems. The method includes providing a drug solution comprising drug ions and associated counterions; adjusting the pH of the drug solution by contacting the drug solution with a ion exchange material first; separating the ion exchange material from the pH-adjusted drug solution; and buffering the pH-adjusted drug solution with a buffer. A peptidic buffer is preferably used. The methods result in compositions suitable for use in electrotransport delivery systems.

    摘要翻译: 制备用于电转运系统的组合物的方法。 该方法包括提供包含药物离子和相关联的抗衡离子的药物溶液; 首先通过使药液与离子交换材料接触来调节药液的pH值; 将离子交换材料与pH调节药液分离; 并用缓冲液缓冲pH调节的药物溶液。 优选使用肽缓冲剂。 该方法导致组合物适用于电转运递送系统。

    Methods for preparing polymeric buffer formulations for electrotransport applications
    3.
    发明申请
    Methods for preparing polymeric buffer formulations for electrotransport applications 审中-公开
    制备用于电转运应用的聚合物缓冲剂配方的方法

    公开(公告)号:US20050129655A1

    公开(公告)日:2005-06-16

    申请号:US10994004

    申请日:2004-11-19

    摘要: The present invention provides methods for preparing compositions for use in electrotransport delivery systems that comprise providing a drug solution comprising drug ions and associated counterions; adjusting the pH of the drug solution by contacting the drug solution with a first ion exchange material; separating the first ion exchange material from the pH-adjusted drug solution; adding the pH-adjusted drug solution to a reservoir of an electrotransport delivery system; and contacting the pH-adjusted drug solution with a second ion exchange material.

    摘要翻译: 本发明提供了用于制备用于电转运递送系统的组合物的方法,其包括提供包含药物离子和相关抗衡离子的药物溶液; 通过使药液与第一离子交换材料接触来调节药液的pH; 将第一离子交换材料与pH调节药液分离; 将pH调节的药物溶液加入到电转运递送系统的储存器中; 并将pH调节的药物溶液与第二离子交换材料接触。